• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
EDSA

EDSA

Edesa Biotech, Inc.

NASDAQHealthcareBiotechnologyCA

USD6.86

+0.03 (+0.44%)

Rating:C-

Company Profile

CEO

Pardeep Nijhawan

IPO Date

2010-06-21

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

CA

Market Metrics

Open

$6.72

Prev. Close

$6.83

Day Low

$6.51

Day High

$7.09

52W Low

$0.72

52W High

$20.32

Market Cap

$0.06B

Volume

0.15M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

58.0%

Avg Negative

1.5%

Avg Neutral

40.3%

News Feed

Edesa Biotech Provides Update For COVID-19 Antibody Trial

Benzinga·8/26/2021·↑ positive

Edesa Biotech Enrolls More Than 525 COVID-19 Patients Ahead of Schedule

Accesswire·8/26/2021·↑ positive

Edesa Biotech Reports Fiscal 3rd Quarter 2021 Financial Results

Accesswire·8/13/2021·↑ positive

Edesa Biotech Extends Dermatitis Study to Canada

Accesswire
·7/13/2021
·↑ positive

EDSA Stock Price Increases Over 14% Pre-Market: Why It Happened

Pulse2·6/18/2021·↑ positive

Edesa Biotech Reports Favorable Review of COVID-19 Study

Accesswire·6/18/2021·↑ positive

Edesa Biotech to Attend BIO Digital 2021

Accesswire·6/8/2021·↑ positive

Edesa Biotech's EB01 Shows Encouraging Interim Results In Dermatitis Trial

Benzinga·6/3/2021·↑ positive

Edesa Biotech Reports Positive Interim Results in Dermatitis Trial

Accesswire·6/3/2021·↑ positive

Edesa Biotech to Join Panel Discussion at Industry Event

Accesswire·5/28/2021·↑ positive